Pharmaceuticals, personal care products, and endocrine disruptors in water

Implications for the water industry

Shane A. Snyder, Paul Westerhoff, Yeomin Yoon, David L. Sedlak

Research output: Contribution to journalArticle

603 Citations (Scopus)

Abstract

For over 70 years, scientists have reported that certain synthetic and natural compounds could mimic natural hormones in the endocrine systems of animals. These substances are now collectively known as endocrine-disrupting compounds (EDCs), and have been linked to a variety of adverse effects in both humans and wildlife. More recently, pharmaceuticals and personal care products (PPCPs) have been discovered in various surface and ground waters, some of which have been linked to ecological impacts at trace concentrations. The majority of EDCs and PPCPs are more polar than traditional contaminants and several have acidic or basic functional groups. These properties, coupled with occurrence at trace levels (i.e., <1 μg/L), create unique challenges for both removal processes and analytical detection. Reports of EDCs and PPCPs in water have raised substantial concern among the public and regulatory agencies; however, very little is known about the fate of these compounds during drinking and wastewater treatment. Numerous studies have shown that conventional drinking and wastewater treatment plants can not completely remove many EDCs and PPCPs. Oxidation with chlorine and ozone can result in transformation of some compounds with reactive functional groups under the conditions employed in water and wastewater treatment plants. Advanced treatment technologies, such as activated carbon and reverse osmosis, appear viable for the removal of many trace contaminants including EDCs and PPCPs. Future research needs include more detailed fate and transport data, standardized analytical methodology, predictive models, removal kinetics, and determination of the toxicological relevance of trace levels of EDCs and PPCPs in water.

Original languageEnglish (US)
Pages (from-to)449-469
Number of pages21
JournalEnvironmental Engineering Science
Volume20
Issue number5
StatePublished - 2003

Fingerprint

Endocrine Disruptors
endocrine disruptor
water industry
Drug products
Water
Wastewater treatment
Pharmaceutical Preparations
Industry
drinking
water
Functional groups
functional group
Impurities
endocrine system
pollutant
Ozone
Chlorine
Hormones
Reverse osmosis
ecological impact

Keywords

  • Drinking water
  • Endocrine disruptor
  • Pharmaceutical
  • Review
  • Treatment
  • Wastewater

ASJC Scopus subject areas

  • Environmental Engineering
  • Environmental Science(all)
  • Environmental Chemistry

Cite this

Pharmaceuticals, personal care products, and endocrine disruptors in water : Implications for the water industry. / Snyder, Shane A.; Westerhoff, Paul; Yoon, Yeomin; Sedlak, David L.

In: Environmental Engineering Science, Vol. 20, No. 5, 2003, p. 449-469.

Research output: Contribution to journalArticle

@article{b836264c72d6420faba434ccc98d5db0,
title = "Pharmaceuticals, personal care products, and endocrine disruptors in water: Implications for the water industry",
abstract = "For over 70 years, scientists have reported that certain synthetic and natural compounds could mimic natural hormones in the endocrine systems of animals. These substances are now collectively known as endocrine-disrupting compounds (EDCs), and have been linked to a variety of adverse effects in both humans and wildlife. More recently, pharmaceuticals and personal care products (PPCPs) have been discovered in various surface and ground waters, some of which have been linked to ecological impacts at trace concentrations. The majority of EDCs and PPCPs are more polar than traditional contaminants and several have acidic or basic functional groups. These properties, coupled with occurrence at trace levels (i.e., <1 μg/L), create unique challenges for both removal processes and analytical detection. Reports of EDCs and PPCPs in water have raised substantial concern among the public and regulatory agencies; however, very little is known about the fate of these compounds during drinking and wastewater treatment. Numerous studies have shown that conventional drinking and wastewater treatment plants can not completely remove many EDCs and PPCPs. Oxidation with chlorine and ozone can result in transformation of some compounds with reactive functional groups under the conditions employed in water and wastewater treatment plants. Advanced treatment technologies, such as activated carbon and reverse osmosis, appear viable for the removal of many trace contaminants including EDCs and PPCPs. Future research needs include more detailed fate and transport data, standardized analytical methodology, predictive models, removal kinetics, and determination of the toxicological relevance of trace levels of EDCs and PPCPs in water.",
keywords = "Drinking water, Endocrine disruptor, Pharmaceutical, Review, Treatment, Wastewater",
author = "Snyder, {Shane A.} and Paul Westerhoff and Yeomin Yoon and Sedlak, {David L.}",
year = "2003",
language = "English (US)",
volume = "20",
pages = "449--469",
journal = "Environmental Engineering Science",
issn = "1092-8758",
publisher = "Mary Ann Liebert Inc.",
number = "5",

}

TY - JOUR

T1 - Pharmaceuticals, personal care products, and endocrine disruptors in water

T2 - Implications for the water industry

AU - Snyder, Shane A.

AU - Westerhoff, Paul

AU - Yoon, Yeomin

AU - Sedlak, David L.

PY - 2003

Y1 - 2003

N2 - For over 70 years, scientists have reported that certain synthetic and natural compounds could mimic natural hormones in the endocrine systems of animals. These substances are now collectively known as endocrine-disrupting compounds (EDCs), and have been linked to a variety of adverse effects in both humans and wildlife. More recently, pharmaceuticals and personal care products (PPCPs) have been discovered in various surface and ground waters, some of which have been linked to ecological impacts at trace concentrations. The majority of EDCs and PPCPs are more polar than traditional contaminants and several have acidic or basic functional groups. These properties, coupled with occurrence at trace levels (i.e., <1 μg/L), create unique challenges for both removal processes and analytical detection. Reports of EDCs and PPCPs in water have raised substantial concern among the public and regulatory agencies; however, very little is known about the fate of these compounds during drinking and wastewater treatment. Numerous studies have shown that conventional drinking and wastewater treatment plants can not completely remove many EDCs and PPCPs. Oxidation with chlorine and ozone can result in transformation of some compounds with reactive functional groups under the conditions employed in water and wastewater treatment plants. Advanced treatment technologies, such as activated carbon and reverse osmosis, appear viable for the removal of many trace contaminants including EDCs and PPCPs. Future research needs include more detailed fate and transport data, standardized analytical methodology, predictive models, removal kinetics, and determination of the toxicological relevance of trace levels of EDCs and PPCPs in water.

AB - For over 70 years, scientists have reported that certain synthetic and natural compounds could mimic natural hormones in the endocrine systems of animals. These substances are now collectively known as endocrine-disrupting compounds (EDCs), and have been linked to a variety of adverse effects in both humans and wildlife. More recently, pharmaceuticals and personal care products (PPCPs) have been discovered in various surface and ground waters, some of which have been linked to ecological impacts at trace concentrations. The majority of EDCs and PPCPs are more polar than traditional contaminants and several have acidic or basic functional groups. These properties, coupled with occurrence at trace levels (i.e., <1 μg/L), create unique challenges for both removal processes and analytical detection. Reports of EDCs and PPCPs in water have raised substantial concern among the public and regulatory agencies; however, very little is known about the fate of these compounds during drinking and wastewater treatment. Numerous studies have shown that conventional drinking and wastewater treatment plants can not completely remove many EDCs and PPCPs. Oxidation with chlorine and ozone can result in transformation of some compounds with reactive functional groups under the conditions employed in water and wastewater treatment plants. Advanced treatment technologies, such as activated carbon and reverse osmosis, appear viable for the removal of many trace contaminants including EDCs and PPCPs. Future research needs include more detailed fate and transport data, standardized analytical methodology, predictive models, removal kinetics, and determination of the toxicological relevance of trace levels of EDCs and PPCPs in water.

KW - Drinking water

KW - Endocrine disruptor

KW - Pharmaceutical

KW - Review

KW - Treatment

KW - Wastewater

UR - http://www.scopus.com/inward/record.url?scp=0141828302&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141828302&partnerID=8YFLogxK

M3 - Article

VL - 20

SP - 449

EP - 469

JO - Environmental Engineering Science

JF - Environmental Engineering Science

SN - 1092-8758

IS - 5

ER -